login
  Password reminder
NeuroNews
Contact the editor Visit NeuroNews Twitter feed Visit NeuroNews Facebook page
 

Encouraging early clinical results with Woven Endobridge cerebral aneurysm device


Friday, 16 Dec 2011 12:53

Flow diversion is a new approach for the endovascular treatment of intracranial aneurysms. The Woven Endobridge (WEB II, from Sequent Medical) cerebral aneurysm embolization device is an intrasaccular, oblate, braided-wire designed to provide flow disruption at the aneurysm neck-parent artery interface. A new study suggests that early data from the first two patients treated with the device is hopeful. 


A study published in August 2011 in the journal Neuroradiology suggests that the intrasaccular deployment of self-expanding, compliant, cylindrical, high-density, braided metallic mesh constructs could represent a reasonable approach as an endovascular treatment of cerebral aneurysms.


Investigators Joachim Klisch, Department of Diagnostic and Interventional Radiology and Neuroradiology, Helios General Hospital, Erfurt, Germany, and colleagues set out to evaluate the acute and short-term performance of the WEB II device regarding the immediacy, degree, and durability of aneurysm occlusion in two patients.


Klisch et al implanted the WEB II device in one patient with an unruptured middle cerebral artery trifurcation aneurysm and in another with an unruptured basilar tip aneurysm. They then graded the degree of intra-aneurysmal flow disruption based on serial digital subtraction aneurysm angiography performed over 30 min immediately following device implantation and at eight weeks. The team also performed immediate and eight-week post-treatment CT and 3-T MRI studies.


The authors wrote in the journal, “Delivery and deployment of the WEB II device was technically straightforward and achieved without complications.” Further, they noted that neither of the two devices required retrieval or repositioning after full deployment and there were no periprocedural thrombembolic or haemorrhagic complications. “In both cases, complete aneurysm occlusion was observed within minutes of device deployment. Short-term angiographic follow-up confirmed stable complete occlusion at eight weeks,” they noted. The authors also recommended in the paper that further clinical studies and long-term follow-up with the device should be pursued.


Tom Wilder, president and CEO of Sequent Medical told NeuroNews, “Sequent Medical is conducting a controlled release of the WEB Aneurysm Embolization system, which bears the CE mark, at a number of selected centres in Europe in order to gain further clinical experience. The company intends to initiate a number of clinical studies during 2012.”

 




Add New Comment

Most popular


MR CLEAN: Better outcomes with intervention in ischaemic stroke patients
Thursday, 18 Dec 2014
For the first time, the Multicentre randomised clinical trial of endovascular treatment for acute ischaemic stroke in the Netherlands (MR CLEAN) has shown better outcomes in favour of intervention in ... MR CLEAN: Better outcomes with intervention in ischaemic stroke patients

Philips launches DoseWise Portal radiation dose management software
Monday, 01 Dec 2014
Royal Philips has introduced the DoseWise Portal, a comprehensive radiation dose management software solution aimed at managing radiation exposure risk to patients and their caregivers. Philips launches DoseWise Portal radiation dose management software

PulseRider safe and effective in early USA experience
Thursday, 08 Jan 2015
Initial experience with PulseRider (Pulsar Vascular) has shown the device to be safe and effective as an adjunct in the treatment of bifurcation aneurysms arising at the basilar apex or carotid ... PulseRider safe and effective in early USA experience

Features


TeleStroke Units improve stroke care in underserved areas
Wednesday, 07 Jan 2015
Peter Müller-Barna writes that the use of telemedicine to ensure 24/7 access to consultation and care in rural areas is one of the major recommendations of the American Stroke Association in their ... TeleStroke Units improve stroke care in underserved areas

Impact“ful” moments
Friday, 05 Dec 2014
Once a year, in almost ritualised fashion, the editors of peer-reviewed journals anxiously await publication of the Thomson Reuters Impact Factor. Journals in the “neuro” space are no exception to ... Impact“ful” moments

Profiles


Joseph Broderick
Wednesday, 07 Jan 2015
Joseph Broderick speaks to NeuroNews about the future of neurology and his research, in particular, ... Joseph Broderick

Vladimír Beneš Jr
Tuesday, 30 Sep 2014
Vladimír Beneš Jr is professor and chair at the First Medical School, Charles University, P... Vladimír Beneš Jr

Cardiac Rhythm News Vascular News Cardiovascular News Interventional News Spinal News NeuroNews
BIBA Medical BIBA MedTech Insights CX Symposium ilegx
 
Password Reminder

BIBA Medical, 526 Fulham Road, Fulham, London, SW6 5NR.
TEL: +44 (0)20 7736 8788 FAX: +44 (0)20 7736 8283 EMAIL: 
info@bibamedical.com
© BIBA Medical Ltd is a company registered in England and Wales with company number 2944429.
VAT registration number 730 6811 50.
Site Map | Terms and Conditions